OSX strikes orthopaedic deal for 5 Middle East countries
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Osteopore Ltd. has announced a distribution agreement with Al-Umnia Medical LLC to expand its orthopaedic product segment into five Middle Eastern countries, including Saudi Arabia and the UAE. The agreement is for a three-year period, with an option for extension, and focuses on orthopaedic bone reconstruction products. CEO Dr. Yujing Lim expressed enthusiasm about this commercial expansion, highlighting Al-Umnia's strong regional presence and commitment to clinical education and support.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Osteopore
- Details of Auditor Appointment/Resignation
- OSX completes first Hainan custom orthopaedic implant
- Activities Report June 2026 and Appendix 4C
- OSX secures Hainan FDA approval for orthopaedic devices
- Activities Report March 2026 and Appendix 4C
Later from Osteopore
- Half Yearly Report and Accounts
- OSX secures market access to Thailand orthopaedic market
- Resignation and appointment of Company Secretary
- Activities Report September 2026 and Appendix 4C
- OSX focuses on Ortho line in Singapore via direct selling
Follow Osteopore into a list and get an email when it puts out news.
Follow Osteopore